Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) EV/Assets Ratio: 1.91x

Is Hologic, Inc.’s EV/Assets ratio high or low?

Hologic, Inc.'s EV/Assets ratio of 1.91x is in line with its 5-year average of 2.08x, near the low end of its 5-year range (1.52x–2.91x).

The EV/Assets ratio for Hologic, Inc. (HOLX) is 1.91x as of Wednesday, June 10, 2026. It is above its 12-month average by 3.57% (1.84x).

HOLX EV/Assets Ratio Chart

HOLX EV/Assets Ratio
1.91x+11.05% 1Y
Zoom

HOLX Average EV/Assets Ratio Chart

HOLX Current vs Average EV/Assets Ratio Chart

HOLX EV/Assets Ratio Metrics

EV/ASSETS RATIO

1.91x

EV/ASSETS RATIO AVG TTM

1.84x

EV/ASSETS RATIO AVG 3Y

1.98x

EV/ASSETS RATIO AVG 5Y

2.08x

EV/ASSETS RATIO AVG 10Y

2.12x

EV/ASSETS RATIO AVG 15Y

1.82x

EV/ASSETS RATIO AVG 20Y

1.90x

CURRENT VS TTM AVG

+3.57%

CURRENT VS 3Y AVG

-3.55%

CURRENT VS 5Y AVG

-8.36%

CURRENT VS 10Y AVG

-10.02%

CURRENT VS 15Y AVG

+5.05%

CURRENT VS 20Y AVG

+0.56%

HOLX Competitors' EV/Assets Ratio

NAMEMARKET CAPEV/ASSETS RATIOTTM3Y5Y
Hologic, Inc. (HOLX)$16.97B1.91x1.84x1.98x2.08x
Moderna, Inc. (MRNA)$18.40B1.55x1.14x1.48x2.53x
Align Technology, Inc. (ALGN)$12.56B1.84x1.76x2.56x3.77x
BioNTech SE (BNTX)$21.81B0.44x0.55x0.54x1.39x
Mettler-Toledo International Inc. (MTD)$22.85B6.85x8.27x8.63x9.33x
Baxter International Inc. (BAX)$10.49B0.91x0.91x1.05x1.32x
Waters Corporation (WAT)$23.83B1.43x4.12x4.55x5.47x
Charles River Laboratories International, Inc. (CRL)$9.06B1.56x1.50x1.60x1.95x
Bio-Rad Laboratories, Inc. (BIO)$7.89B0.89x0.88x0.89x0.99x
Veeva Systems Inc. (VEEV)$26.73B2.78x4.63x5.33x6.99x

Hologic, Inc. EV/Assets Ratio Formula & Definition

EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. EV/Assets Ratio FAQ

What is the EV/Assets ratio for Hologic, Inc. (HOLX)?
The EV/Assets ratio for HOLX stock is 1.91x.
Is Hologic, Inc.'s EV/Assets ratio high or low?
Hologic, Inc.'s EV/Assets ratio of 1.91x is in line with its 5-year average of 2.08x, near the low end of its 5-year range (1.52x–2.91x).
What is the TTM average EV/Assets ratio for Hologic, Inc. (HOLX)?
The TTM average EV/Assets ratio for HOLX stock is 1.84x.
What is the 3Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
The 3Y average EV/Assets ratio for HOLX stock is 1.98x.
What is the 5Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
The 5Y average EV/Assets ratio for HOLX stock is 2.08x.
What is the 10Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
The 10Y average EV/Assets ratio for HOLX stock is 2.12x.
What is the 15Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
The 15Y average EV/Assets ratio for HOLX stock is 1.82x.
What is the 20Y average EV/Assets ratio for Hologic, Inc. (HOLX)?
The 20Y average EV/Assets ratio for HOLX stock is 1.90x.

Hologic, Inc. EV/Assets Ratio History

DATEEV/ASSETS RATIO
2026-04-071.91x
2026-04-061.91x
2026-04-021.90x
2026-04-011.90x
2026-03-311.90x
2026-03-301.90x
2026-03-271.90x
2026-03-261.90x
2026-03-251.90x
2026-03-241.90x
2026-03-231.90x
2026-03-201.89x
2026-03-191.89x
2026-03-181.89x
2026-03-171.88x
2026-03-161.89x
2026-03-131.89x
2026-03-121.89x
2026-03-111.89x
2026-03-101.90x
2026-03-091.90x
2026-03-061.90x
2026-03-051.90x
2026-03-041.90x
2026-03-031.89x
2026-03-021.89x
2026-02-271.89x
2026-02-261.89x
2026-02-251.89x
2026-02-241.89x
2026-02-231.89x
2026-02-201.89x
2026-02-191.89x
2026-02-181.89x
2026-02-171.89x
2026-02-131.88x
2026-02-121.88x
2026-02-111.89x
2026-02-101.89x
2026-02-091.88x
2026-02-061.88x
2026-02-051.88x
2026-02-041.87x
2026-02-031.87x
2026-02-021.88x
2026-01-301.88x
2026-01-291.88x
2026-01-281.95x
2026-01-271.96x
2026-01-261.96x
2026-01-231.95x
2026-01-221.95x
2026-01-211.96x
2026-01-201.95x
2026-01-161.95x
2026-01-151.95x
2026-01-141.96x
2026-01-131.95x
2026-01-121.95x
2026-01-091.95x
2026-01-081.95x
2026-01-071.95x
2026-01-061.95x
2026-01-051.95x
2026-01-021.94x
2025-12-311.94x
2025-12-301.94x
2025-12-291.94x
2025-12-261.94x
2025-12-241.94x
2025-12-231.95x
2025-12-221.95x
2025-12-191.95x
2025-12-181.95x
2025-12-171.95x
2025-12-161.95x
2025-12-151.96x
2025-12-121.95x
2025-12-111.95x
2025-12-101.95x
2025-12-091.95x
2025-12-081.95x
2025-12-051.95x
2025-12-041.95x
2025-12-031.95x
2025-12-021.95x
2025-12-011.95x
2025-11-281.95x
2025-11-261.95x
2025-11-251.95x
2025-11-241.95x
2025-11-211.94x
2025-11-201.93x
2025-11-191.93x
2025-11-181.93x
2025-11-171.99x
2025-11-141.99x
2025-11-131.99x
2025-11-122.00x
2025-11-112.00x
2025-11-101.99x
2025-11-071.99x
2025-11-061.99x
2025-11-051.99x
2025-11-041.99x
2025-11-031.99x
2025-10-311.98x
2025-10-301.98x
2025-10-291.98x
2025-10-281.98x
2025-10-271.98x
2025-10-241.98x
2025-10-231.98x
2025-10-221.98x
2025-10-211.98x
2025-10-201.93x
2025-10-171.88x
2025-10-161.84x
2025-10-151.80x
2025-10-141.78x
2025-10-131.77x
2025-10-101.82x
2025-10-091.85x
2025-10-081.84x
2025-10-071.82x
2025-10-061.81x
2025-10-031.84x
2025-10-021.83x
2025-10-011.81x
2025-09-301.82x
2025-09-291.81x
2025-09-261.81x
2025-09-251.77x
2025-09-241.79x
2025-09-231.82x
2025-09-221.81x
2025-09-191.79x
2025-09-181.84x
2025-09-171.84x
2025-09-161.71x
2025-09-151.72x
2025-09-121.74x
2025-09-111.79x
2025-09-101.77x
2025-09-091.80x
2025-09-081.79x
2025-09-051.80x
2025-09-041.79x
2025-09-031.79x
2025-09-021.79x
2025-08-291.81x
2025-08-281.80x
2025-08-271.80x
2025-08-261.80x
2025-08-251.81x
2025-08-221.84x
2025-08-211.81x
2025-08-201.85x
2025-08-191.83x
2025-08-181.81x
2025-08-151.83x
2025-08-141.83x
2025-08-131.86x
2025-08-121.83x
2025-08-111.83x
2025-08-081.83x
2025-08-071.83x
2025-08-061.80x
2025-08-051.83x
2025-08-041.83x
2025-08-011.81x
2025-07-311.80x
2025-07-301.85x
2025-07-291.87x
2025-07-281.86x
2025-07-251.89x
2025-07-241.88x
2025-07-231.87x
2025-07-221.86x
2025-07-211.81x
2025-07-181.82x
2025-07-171.82x
2025-07-161.82x
2025-07-151.80x
2025-07-141.84x
2025-07-111.87x
2025-07-101.90x
2025-07-091.87x
2025-07-081.84x
2025-07-071.83x
2025-07-031.84x
2025-07-021.85x
2025-07-011.86x
2025-06-301.85x
2025-06-271.85x
2025-06-261.85x
2025-06-251.83x
2025-06-241.84x
2025-06-231.83x
2025-06-201.83x
2025-06-181.82x
2025-06-171.82x
2025-06-161.85x
2025-06-131.84x
2025-06-121.85x
2025-06-111.84x
2025-06-101.85x
2025-06-091.83x
2025-06-061.83x
2025-06-051.80x
2025-06-041.78x
2025-06-031.79x
2025-06-021.77x
2025-05-301.77x
2025-05-291.79x
2025-05-281.81x
2025-05-271.77x
2025-05-231.56x
2025-05-221.57x
2025-05-211.58x
2025-05-201.62x
2025-05-191.62x
2025-05-161.63x
2025-05-151.60x
2025-05-141.59x
2025-05-131.64x
2025-05-121.68x
2025-05-091.63x
2025-05-081.61x
2025-05-071.59x
2025-05-061.53x
2025-05-051.52x
2025-05-021.56x
2025-05-011.61x
2025-04-301.63x
2025-04-291.64x
2025-04-281.63x
2025-04-251.63x
2025-04-241.64x
2025-04-231.63x
2025-04-221.63x
2025-04-211.60x
2025-04-171.62x
2025-04-161.59x
2025-04-151.63x
2025-04-141.65x
2025-04-111.63x
2025-04-101.61x
2025-04-091.66x
2025-04-081.64x
2025-04-071.72x
2025-04-041.71x
2025-04-031.73x
2025-04-021.70x
2025-04-011.72x
2025-03-311.73x
2025-03-281.72x
2025-03-271.74x
2025-03-261.72x
2025-03-251.70x

Showing the most recent 260 of 5,030 data points. The chart above shows the full history.

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini